SARS-CoV-2 3CLpro-IN-20

SKU: orb1819011

Description

SARS-CoV-2 3CLpro-IN-20 is a covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.43 μM. This compound demonstrates antiviral activity in vitro and is a useful research tool for studying coronavirus replication and screening for potential therapeutic agents.

Research Area

Immunology & Inflammation, Infectious Disease & Virology

Images & Validation

−

Key Properties

−

CAS Number	878985-00-3
MW	366.21
Purity	97.25%
Formula	C₁₉H₁₂BrNO₂
SMILES	C(N1C=2C(C(=O)C1=O)=CC(Br)=CC2)C3=CC4=C(C=C3)C=CC=C4
Target	Antiviral,SARS-CoV
Solubility	DMSO:3.67 mg/mL (10.02 mM)

Bioactivity

−

Target IC50	3CLpro (SARS CoV-2):0.43 μM

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Antiviral, SARSCoV, SARS-CoV-2 3CL, SARS-CoV-2 3CLpro-IN-20, SARSCoV23CLproIN20

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

4035834 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols